Supplementary Figure 1 from The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in <i>PIK3CA</i>-Mutant Breast Cancer Brain Metastases

Franziska M. Ippen,Christopher A. Alvarez-Breckenridge,Benjamin M. Kuter,Alexandria L. Fink,Ivanna V. Bihun,Matthew Lastrapes,Tristan Penson,Stephen P. Schmidt,Gregory R. Wojtkiewicz,Jianfang Ning,Megha Subramanian,Anita Giobbie-Hurder,Maria Martinez-Lage,Scott L. Carter,Daniel P. Cahill,Hiroaki Wakimoto,Priscilla K. Brastianos

crossref（2023）

引用 0|浏览31

暂无评分

摘要

Western blot analysis of p-p44/42 MAPK (Erk1/2) (Thr202/Tyr204), p-MEK1/2 (Ser217/221), p-p90RSK (Ser380), p-MSK1 (Thr581) in JIMT-1 BR-3, MDA-MB-361, MDA-MB-231 BrM2 and BS-004 cell lines treated with GDC-0084 in increasing concentrations for a total of 6 hours

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure 1 from The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in &lt;i&gt;PIK3CA&lt;/i&gt;-Mutant Breast Cancer Brain Metastases

Supplementary Figure 1 from The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in <i>PIK3CA</i>-Mutant Breast Cancer Brain Metastases